文 | vb动脉网年前买入中国创新药资产的投资人赚翻了！今年以来，聚焦港股创新药的恒生医药ETF（159892）涨幅超90%，其跟踪的恒生生物科技指数年内涨幅也逼近90%，甚至一度突破100%。另外，部分创新药个股实现翻倍增长。从年初开盘至今（7月31日），德琪医药涨幅达796.83%，和铂医药涨幅约 472.22%，三生制药涨幅约466.43%， 歌礼制药涨幅约273.06%……毫无疑问，创新药...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.